Solvay Pharma Россия и СНГ Обратная связь Карта сайта
Среда, 31 декабря 2008 г.
Сделать стартовойДобавить в избранноеСообщить о странице другуW@PAvantGoPDA
В стремлении к прогрессу, с заботой о людях
Фемостон
Регистрация
Медицинские новости
XV Российский национальный конгресс "Человек и лекарство"

- сайт для специалистов и не только.
Консультации по вопросам диагностики и лечения
урологических и андрологических заболеваний.

Библиография

  1. Miller VT, Muesing RA, LaRosa JC, Stoy DB, Phillips EA, Stillman RJ. Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions and apolipoprotein A-l. Obstetrics and Gynecology 1991; 77: 235-240.
  2. Whitehead Ml, Hillard TC, Crook D. The role and use of progestogens. Obstetrics and Gynecology 1990; 75: 59S-76S.
  3. Rozenbaum H. Relationships between chemical structure and biological properties of progestogens. American Journal of Obstetrics and Gynecology 1982;142:719-724.
  4. Kuhl H. Pharmacokinetics of oestrogens and progestogens. Maturitas 1990: 12:171-197.
  5. Scholer HFL, De Wachter AM. Biological properties of 9,10-isomeric steroids. I. Progestational activity of 9p, 10а-steroids. Acta Endocrinologica 1960; 35: 188-196.
  6. Reerink EH, Scholler HFL, Westerhof P, Querido A, Kassenaar AAH, Diczfalusy E, Tillinger КС. A new class of hormonally active steroids. Nature 1960; 186: 168-169.
  7. Tausk M. A general summary of dydrogesterone, a derivative of retroprogesterone. In: Tausk M ed. International Encyclopaedia of Pharmacology and Therapeutics. Section 48. Pharmacology of the Endocrine System and Related Drugs: Progesterone, Progestational Drugs and Antifertility Drugs, Volume II. Oxford-New York: Pergamon Press, 1972:481.
  8. Claasen V, Morsink L, De Wachter AM. Influence of dydrogesterone (6-dehydroretroprogesterone, Duphaston®) on ovulation in the rat, rabbit and monkey Acta Endocrinologica 1971; 67: 551-562.
  9. Marois M. Action d'un progestatif actif par voie buccale, la dydrogesterone, sur la come utererine de la lapine. Bulletin de L' Academic Nationale de Medecine 1962; 146:324-328.
  10. Marois M. Absence de proprietes masculinisantes ou feminisantes d'un progestatif actif per os, la dydrogesterone, chez Ie rat male ou femelle adulte et chez Ie foetus de rat. [The absence of masculinising or feminising properties of an orally active progestogen, dydrogesterone, in adult male and female rats and in rat foetuses.] Bulletin de L' Academic Nationale de Medecine 1962; 146: 354-364.
  11. Boris A, Stevenson RH, Timal T. Some studies on the endocrine properties of dydrogesterone. Steroids 1966; 7:1-10.
  12. Lane G, Siddle N, Ryder ТА, Pryse-Davies J, King RJB, Whitehead Ml. Effects of dydrogesterone on the oestrogenized postmenopausal endometrium. British Journal of Obstetrics and Gynaecology 1986; 93:55-62.
  13. Morsink L, De Wachter AM. Dydrogesterone (Duphaston®) and the "early-androgen syndrome" Solvay Duphar Data on File Report No. 56649/32/70 (1970).
  14. Vomachka AJ, Paup DC, Coniglio LP, McManus MF, Clemens LG. Progestin-induced pseudohermaphroditism in the female hamster. Journal of Reproduction and Fertility 1974 ; 37: 269-276.
  15. MacDonald GJ. Maintenance of pregnancy in ovariectomised rats with steroid analogues and the reproductive ability of progeny Biological Reproduction 1982; 27: 261-267.



Solvay Pharma Реклама: SOLVAY Придумай свой вопрос и получи приз
Баннерная сеть Солвей-Фарма.ру
Адрес


Последнее обновление  31.12.2008 г.